HB6897: Synthetic Biology and Active Pharmaceutical Ingredients Act
- 1Introduced (current step)
- 2Passed One Chamber
- 3Passed Both Chambers
- 4Became Law
Here is how to read this bill
Start with the summary
It says what the bill does in plain language. The official text is one tab over.
Check where it is
The status badge says how far it has gotten. The History tab lists every step.
Follow it
We will email you when it moves. You need a free account.
Tell someone who votes on it
Email or call the sponsor, or find your own representatives, from the actions panel.
Bill information
Summary
To require the Secretary of Defense to establish a pilot program to evaluate novel pharmaceutical manufacturing technologies to reduce the reliance of the Department on foreign manufacturers for active pharmaceutical ingredients and key starting materials.
Plain-language summary
This bill directs the Secretary of Defense to create a test program that studies new ways to make pharmaceuticals inside the United States. The goal is to reduce dependence on foreign countries for active pharmaceutical ingredients, which are the chemicals that make medicines work. The bill affects the Department of Defense's pharmaceutical supply chain and manufacturing capabilities. The bill was introduced in Congress and is currently in the early legislative stage.
AI-generated summary
What can I do?
It's early in the process — messages to the sponsor and your representatives carry the most weight right now.
Contact Your Representatives
Calling or emailing is the most direct way to weigh in — offices tally constituent contacts.
Find Your RepresentativesShare This Bill
Sharing helps others in your district get informed and involved.
HB6897: Synthetic Biology and Active Pharmaceutical Ingredients Act